Sign in

    Willis Towers Watson PLC (WTW)

    You might also like

    WTW is a company that operates in two main segments: Health, Wealth & Career (HWC) and Risk & Broking. The company provides a variety of services, including advice, broking, solutions, and technology, aimed at enhancing employee benefit plans, institutional investments, compensation, career programs, and overall employee experience . WTW's offerings are designed to address human resources and risk needs, with a focus on growing revenue, improving margins, and increasing cash flow, EBITDA, and earnings through strategic priorities .

    1. Health, Wealth & Career (HWC) - Offers services such as advice, broking, solutions, and technology for employee benefit plans, institutional investors, compensation and career programs, and overall employee experience. Focuses on key areas like Health, Wealth, Career, and Benefits Delivery & Outsourcing .
    2. Risk & Broking - Provides insurance broking and consulting services, influenced by economic conditions and insurance market cycles .
    NamePositionStart DateShort Bio
    Carl A. HessChief Executive OfficerJanuary 1, 2022Carl A. Hess has served as the CEO of WTW since January 1, 2022. He was previously the President from August 16, 2021, and Head of Investment, Risk and Reinsurance from October 27, 2016, to August 16, 2021 .
    Andrew J. KrasnerChief Financial OfficerSeptember 7, 2021Andrew J. Krasner has been the CFO at WTW since September 7, 2021. He was previously the CFO for Assured Partners and held various roles at WTW, including Global Treasurer and Head of M&A .
    Kristy D. BanasChief Human Resources OfficerAugust 16, 2021Kristy D. Banas has been the CHRO at WTW since August 16, 2021. She previously served as Senior Director, Global Talent Advisor for Human Capital & Benefits and held other senior HR roles at WTW .
    Alexis FaberChief Operating OfficerAugust 30, 2021Alexis Faber has been the COO at WTW since August 30, 2021. She was previously the COO for Corporate Risk & Broking and worked in investment banking at Schroder Salomon Smith Barney and Citigroup .
    Matthew S. FurmanGeneral CounselJanuary 4, 2016Matthew S. Furman has served as General Counsel at WTW since January 4, 2016. He was previously EVP and Group General Counsel at Willis Group Holdings and held legal roles at The Travelers Companies and Goldman, Sachs & Co. .
    Adam L. GarrardHead of Risk and BrokingJanuary 1, 2022Adam L. Garrard has been Head of Risk and Broking at WTW since January 1, 2022. He previously served as Head of Corporate Risk and Broking, and International, and held CEO roles for Willis Group Holdings in various regions .
    Julie J. GebauerHead of Health, Wealth and CareerJanuary 1, 2022Julie J. Gebauer has been Head of Health, Wealth and Career at WTW since January 1, 2022. She was previously Head of Human Capital & Benefits and held leadership roles at Towers Watson and Towers Perrin .
    Anne PullumHead of EuropeAugust 30, 2021Anne Pullum has been Head of Europe at WTW since August 30, 2021. She was previously Head of Western Europe and held roles as Chief Administrative Officer and Head of Strategy and Innovation at WTW .
    Imran QureshiHead of North AmericaAugust 30, 2021Imran Qureshi has been Head of North America at WTW since August 30, 2021. He was previously Co-Leader for the U.S. and has held various leadership roles at WTW since March 1999 .
    1. Your Risk & Broking segment achieved organic revenue growth of 10% this quarter, driven by your specialty businesses and increased productivity from new hires . Given that Verita, while growing, is still not contributing significantly to organic growth , how do you plan to sustain this level of growth in R&B, and what specific initiatives are you undertaking to ensure continued outperformance?

    2. With the transformation program's cost savings from this year not expected to have a meaningful impact until 2025 , how do you plan to drive further efficiencies post-2024, and can you detail the specific actions you're implementing now to ensure continued margin expansion beyond the program's conclusion?

    3. You've deliberately moderated growth in your Medicare-related businesses to maximize profitability and improve free cash flow amid increased media buying costs and consumer distraction due to the U.S. elections . How will you navigate these challenges to still achieve your mid-single-digit organic revenue growth target for the Health, Wealth & Career segment, and are there alternative strategies to drive growth without incurring higher acquisition costs?

    4. Unallocated costs increased significantly this quarter, including a $13 million legal provision , but you expect these costs to be similar to 2023 levels for the full year . Can you elaborate on the factors contributing to these unallocated costs and how you plan to manage or reduce them to prevent impacting margins in the second half?

    5. With Lucy Clark joining to lead Risk & Broking, aligning with your focus on specialization and technology , what specific strategic initiatives is she expected to implement in the next 12 to 18 months to enhance growth and profitability, and how will her leadership impact talent acquisition and service differentiation in a competitive market?

    Program DetailsProgram 1
    Approval DateSeptember 20, 2023
    End Date/DurationNo expiration date
    Total additional amount$1.0 billion
    Remaining authorization amount$837 million
    DetailsCan be suspended or discontinued at any time
    YearAmount Due (in millions)Debt TypeInterest Rate (%)% of Total Debt
    2026$549 4.400% senior notes4.400 10.3% = ($549 / $5,308) * 100
    2027$746 4.650% senior notes4.650 14.0% = ($746 / $5,308) * 100
    2028$598 4.500% senior notes4.500 11.3% = ($598 / $5,308) * 100
    2029$725 2.950% senior notes2.950 13.7% = ($725 / $5,308) * 100
    2033$742 5.350% senior notes5.350 14.0% = ($742 / $5,308) * 100
    2043$272 6.125% senior notes6.125 5.1% = ($272 / $5,308) * 100
    2048$396 5.050% senior notes5.050 7.5% = ($396 / $5,308) * 100
    2049$543 3.875% senior notes3.875 10.2% = ($543 / $5,308) * 100
    2054$737 5.900% senior notes5.900 13.9% = ($737 / $5,308) * 100

    Competitors mentioned in the company's latest 10K filing.

    • Aon plc
    • Arthur J. Gallagher & Co.
    • Brown & Brown Inc.
    • Cognizant Technology Solutions Corporation
    • Marsh & McLennan Companies, Inc. ('Marsh & McLennan')
    • Robert Half International Inc.
    • Mercer HR Consulting (a Marsh & McLennan company) - Competitor in the pension consulting industry
    • Milliman - Major competitor in the insurance consulting and software industry
    • Oliver Wyman (a Marsh & McLennan company) - Major competitor in the insurance consulting and software industry
    • Deloitte LLP - Part of the big four accounting firms, competitor in the insurance consulting and software industry
    • Ernst & Young - Part of the big four accounting firms, competitor in the insurance consulting and software industry
    • PricewaterhouseCoopers - Part of the big four accounting firms, competitor in the insurance consulting and software industry
    • KPMG - Part of the big four accounting firms, competitor in the insurance consulting and software industry
    • SunGard - Major competitor in the insurance consulting and software industry
    • Buck Consultants (an HIG Capital Company) - Competitor in the insurance exchange industry
    • Connextions (a United Healthcare company) - Competitor in the insurance exchange industry
    • Automatic Data Processing - Competitor in the insurance exchange industry
    • Fidelity - Competitor in the insurance exchange industry
    • WageWorks - Competitor in account-based health plans and consumer-directed benefits
    • HealthEquity - Competitor in account-based health plans and consumer-directed benefits

    NameStart DateEnd DateReason for Change
    Deloitte & Touche LLP2017PresentCurrent auditor.
    Deloitte LLPN/A2017 The decision was made in recognition that key financial leadership now resides in the United States.

    Recent developments and announcements about WTW.

    Financial Reporting

      Earnings Call

      ·
      13 hours ago

      WTW recently held its Fourth Quarter and Full Year 2024 Earnings Call, where several key points were discussed. The company reported a 5% organic revenue growth for the fourth quarter, with an adjusted operating margin of 36.1%, which increased by 190 basis points compared to the previous year. Excluding TRANZACT, the organic revenue growth was 6% with a 36.6% adjusted operating margin. For the full year, WTW achieved a 5% organic revenue growth, or 6% excluding TRANZACT, and expanded its adjusted operating margin by 190 basis points to 23.9%.

      Management provided forward guidance, indicating expectations for continued high single-digit growth in the Health business in 2025, driven by new business success and a strong current pipeline. The Wealth business is expected to see low single-digit growth, while the Career segment is anticipated to maintain mid-single-digit growth levels.

      Significant comments on market conditions included discussions on the potential impacts of recession and inflation. WTW believes it is well-positioned to manage various economic climates due to its flexible organizational structure and strategic initiatives over the past three years.

      Analyst questions during the call touched on several critical topics. One question addressed the impact of political regulatory changes on WTW's business, to which Carl A. Hess responded that such changes often lead clients to seek WTW's expertise in evaluating and implementing necessary adjustments, a process that has historically benefited the company. Another question focused on the potential recession and inflation impacts, with Hess explaining that while inflation could affect insurance pricing and asset values, WTW's strategic flexibility allows it to manage these challenges effectively.

      Regarding strategic initiatives, WTW highlighted its focus on strengthening core businesses, innovating, and expanding its global footprint. The company also plans to continue investing in talent and platform development to drive sustainable growth and margin expansion.

      Overall, WTW's earnings call reflected a strong performance in 2024 and a positive outlook for 2025, with strategic initiatives aimed at enhancing efficiency and optimizing the business portfolio.

      Earnings Report

      ·
      20 hours ago

      WTW Fourth Quarter and Full Year 2024 Earnings Results

      WTW (NASDAQ: WTW) has released its financial results for the fourth quarter and full year ending December 31, 2024. Below are the key highlights:

      Fourth Quarter 2024 Highlights

      • Revenue: $3.0 billion, a 4% increase compared to Q4 2023. Organic revenue growth was 5%.
      • Net Income: $1.25 billion, a 100% increase from $623 million in Q4 2023.
      • Diluted Earnings Per Share (EPS): $12.25, up 105% from $5.97 in Q4 2023.
      • Adjusted Diluted EPS: $8.13, a 9% increase from $7.44 in Q4 2023.
      • Operating Margin: 29.7%, up 300 basis points from Q4 2023.
      • Adjusted Operating Margin: 36.1%, up 190 basis points from Q4 2023.

      Full Year 2024 Highlights

      • Revenue: $9.93 billion, a 5% increase compared to 2023. Organic revenue growth was also 5%.
      • Net Loss: $88 million, primarily due to over $1 billion in impairment charges related to the sale of TRANZACT.
      • Diluted Loss Per Share: $(0.96), compared to $9.95 in 2023.
      • Adjusted Diluted EPS: $16.93, a 17% increase from $14.49 in 2023.
      • Operating Margin: 6.3%, down 810 basis points from 2023.
      • Adjusted Operating Margin: 23.9%, up 190 basis points from 2023.

      Segment Performance

      Health, Wealth & Career (HWC)

      • Q4 Revenue: $1.85 billion, a 3% increase from Q4 2023.
      • Operating Margin: 41.9%, up 140 basis points from Q4 2023.
      • Drivers: Growth in project work, brokerage income, and retirement services globally. Benefits Delivery & Outsourcing (BD&O) saw a decline due to moderated growth in TRANZACT.

      Risk & Broking (R&B)

      • Q4 Revenue: $1.14 billion, a 6% increase from Q4 2023.
      • Operating Margin: 33.5%, up 60 basis points from Q4 2023.
      • Drivers: Strong client retention and new business activity in Corporate Risk & Broking (CRB), and robust software sales in Insurance Consulting & Technology (ICT).

      Cash Flow and Capital Allocation

      • Free Cash Flow: $1.4 billion for 2024, up from $1.2 billion in 2023, driven by operating margin expansion.
      • Share Repurchases: $901 million in 2024, including $395 million in Q4.
      • Dividends Paid: $354 million for the year.

      Strategic Outlook

      WTW's CEO, Carl Hess, highlighted the company's momentum entering 2025, emphasizing the successful completion of its "Grow, Simplify, and Transform" strategy. The company aims to accelerate performance, enhance efficiency, and optimize its portfolio to deliver innovative solutions and shareholder value.

      For further details, WTW will host a conference call on February 4, 2025, at 9:00 a.m. Eastern Time.


      Sources: , , ,

      Auditor Changes

      ·
      Mar 3, 2017, 12:00 AM

      Willis Towers Watson (WTW) Auditor Change

      On March 2, 2017, Willis Towers Watson Public Limited Company (WTW) changed its independent registered public accounting firm from Deloitte LLP (UK) to Deloitte & Touche LLP (US). This decision was approved by the Audit and Risk Committee of the Company's Board of Directors. The change was made to align with the company's key financial leadership, which is now based in the United States. Deloitte LLP (UK) resigned on the same date, and there were no disagreements or reportable events during their tenure .